End to end CDMO services for the importation, encapsulation and distribution of T3S and Placebo for the LIONNS-D2 Trial

{
  "buyer": {
    "id": "GB-PPON-PHVT-4343-HWYR",
    "name": "Cardiff University"
  },
  "date": "2026-01-16T17:31:02Z",
  "id": "004093-2026",
  "initiationType": "tender",
  "language": "en",
  "ocid": "ocds-h6vhtk-05ea44",
  "parties": [
    {
      "address": {
        "country": "GB",
        "countryName": "United Kingdom",
        "locality": "Cardiff",
        "postalCode": "CF24 4HQ",
        "region": "UKL22",
        "streetAddress": "Procurement Services"
      },
      "contactPoint": {
        "email": "rower4@cardiff.ac.uk"
      },
      "details": {
        "classifications": [
          {
            "description": "Public authority - sub-central government",
            "id": "publicAuthoritySubCentralGovernment",
            "scheme": "UK_CA_TYPE"
          },
          {
            "description": "Welsh devolved regulations apply",
            "id": "GB-WLS",
            "scheme": "UK_CA_DEVOLVED_REGULATIONS"
          }
        ],
        "url": "http://www.cardiff.ac.uk/business/why-work-with-us/for-suppliers"
      },
      "id": "GB-PPON-PHVT-4343-HWYR",
      "identifier": {
        "id": "PHVT-4343-HWYR",
        "scheme": "GB-PPON"
      },
      "name": "Cardiff University",
      "roles": [
        "buyer"
      ]
    }
  ],
  "tag": [
    "tender"
  ],
  "tender": {
    "aboveThreshold": true,
    "awardPeriod": {
      "endDate": "2026-03-30T23:59:59+01:00"
    },
    "description": "The School of Medicine successfully applied for a UKRI grant to investigate in a randomised controlled trial (RCT), a new IMP (investigational medicinal product) called Triiodothyronine sulphate (T3S) in hypothyroid subjects with a gene difference in a thyroid related enzyme called deiodinase 2 (D2).\nWe are looking for a CDMO to (i) Import and QP sign off T3S and matched placebo tablets obtained from Ardena, Pamplona, Spain who will manufacture these to GMP standards; (ii) over encapsulate commercially secured L-thyroxine (LT4 ) and matched placebo capsules; (iii) store T3S and matched placebo obtained from Ardena, and over encapsulated LT4 and matched placebo; (iv) label T3S, LT4 and respective placebo packs for distribution to trial subjects; (v) distribute T3S and matched placebo and over encapsulated LT4 and matched placebo packs to trial pharmacy (Royal Glamorgan Hospital, Wales).",
    "documents": [
      {
        "description": "PLEASE NOTE - Returning of a SIGNED COPY of the attached NDA is required to gain access to the tender on our portal. Please ensure an NDA is sent to the below email addresses without delay to allow us to add your organisation to the tender activity. NDAs returned per the linked PPN UK4 notice will automatically qualify for access to this tender, a second NDA for those who have already returned an NDA is not required.\nOnce received, you will be added to the portal to review documentation and submit a bid. Please note, we can only add organisations who have an account on our portal, please ensure you have registered, otherwise we will be unable to add you until this is done. \nReturn of NDA - \nrower4@cardiff.ac.uk\nprocurement@cardiff.ac.uk\nPortal - \nhttps://in-tendhost.co.uk/cardiffuniversity/aspx/Home",
        "documentType": "biddingDocuments",
        "id": "L-1",
        "url": "https://www.sell2wales.gov.wales/Assets/NoticeBuilder_FileDownload.aspx?id=357392"
      },
      {
        "accessDetails": "Upon return of the attached NDA, and registration on or Portal, prospective bidders will have access to all documents on our E-tender portal InTend. Please use the below link to register and access said documents once added to the tender event - \nhttps://in-tendhost.co.uk/cardiffuniversity/aspx/Home",
        "documentType": "biddingDocuments",
        "id": "future"
      },
      {
        "description": "Not published",
        "documentType": "conflictOfInterest",
        "id": "conflictOfInterest"
      },
      {
        "datePublished": "2026-01-16T17:31:02Z",
        "description": "Tender notice on Find a Tender",
        "documentType": "tenderNotice",
        "format": "text/html",
        "id": "004093-2026",
        "noticeType": "UK4",
        "url": "https://www.find-tender.service.gov.uk/Notice/004093-2026"
      }
    ],
    "enquiryPeriod": {
      "endDate": "2026-01-28T23:59:00+00:00"
    },
    "id": "ocds-h6vhtk-05ea44",
    "items": [
      {
        "additionalClassifications": [
          {
            "description": "Pharmaceutical products",
            "id": "33600000",
            "scheme": "CPV"
          },
          {
            "description": "Research and experimental development services",
            "id": "73100000",
            "scheme": "CPV"
          }
        ],
        "deliveryAddresses": [
          {
            "country": "GB",
            "countryName": "United Kingdom",
            "region": "UKL22"
          }
        ],
        "id": "1",
        "relatedLot": "1"
      }
    ],
    "legalBasis": {
      "id": "2023/54",
      "scheme": "UKPGA",
      "uri": "https://www.legislation.gov.uk/ukpga/2023/54/contents"
    },
    "lots": [
      {
        "awardCriteria": {
          "criteria": [
            {
              "name": "Quality",
              "numbers": [
                {
                  "number": 60.0,
                  "weight": "percentageExact"
                }
              ],
              "type": "quality"
            },
            {
              "name": "Responsible Procurement",
              "numbers": [
                {
                  "number": 10.0,
                  "weight": "percentageExact"
                }
              ],
              "type": "quality"
            },
            {
              "name": "Pricing",
              "numbers": [
                {
                  "number": 30.0,
                  "weight": "percentageExact"
                }
              ],
              "type": "price"
            }
          ]
        },
        "contractPeriod": {
          "endDate": "2027-10-11T23:59:59+01:00",
          "startDate": "2026-04-20T00:00:00+01:00"
        },
        "id": "1",
        "selectionCriteria": {
          "criteria": [
            {
              "description": "Relevant professional accreditations - further detail found in Tender Pack ",
              "type": "technical"
            }
          ]
        },
        "status": "active",
        "suitability": {
          "sme": true
        },
        "value": {
          "amount": 421000,
          "amountGross": 421000,
          "currency": "GBP"
        }
      }
    ],
    "mainProcurementCategory": "services",
    "procedure": {
      "acceleratedRationale": "Qualifying planned procurement notice",
      "features": "Due to the sensitivity of the research project, prospective bidders will be required to return an NDA (attached to this notice and the previous UK4 PPN notice) to us before being given access to the full Tender Pack on our E-tender portal InTend. Prospective bidders will then be manually added once registered on said portal, and upon receipt of a signed NDA. \nThe Tender structure will be as follows - \nReturn of NDA (if not already done during PPN notice period)\nCountersigned version sent back for your records\nAddition to the Tender on our E-tender portal\nInitial Bidding stage as normal - requiring return of pricing and responses to quality questions \nEvaluation to determine a winning/preferred bid\nNegotiation of the MSA Terms and Conditions\nCommunication of winning bidder following successful negotiation of MSA\nStandstill\nContract Signature\nContract Execution",
      "isAccelerated": true
    },
    "procurementMethod": "open",
    "procurementMethodDetails": "Competitive flexible procedure",
    "status": "active",
    "submissionMethodDetails": "NDAs are to be returned to the following email addresses - \nrower4@cardiff.ac.uk\nprocurement@cardiff.ac.uk\nRegistration and access to the tender is via our portal - \nhttps://in-tendhost.co.uk/cardiffuniversity/aspx/Home",
    "submissionTerms": {
      "electronicSubmissionPolicy": "allowed",
      "languages": [
        "en",
        "cy"
      ]
    },
    "tenderPeriod": {
      "endDate": "2026-01-30T23:59:00+00:00"
    },
    "title": "End to end CDMO services for the importation, encapsulation and distribution of T3S and Placebo for the LIONNS-D2 Trial",
    "value": {
      "amount": 421000,
      "amountGross": 421000,
      "currency": "GBP"
    }
  }
}